Andrea O Fontana1, Mary Gonzalez Melo2, Gilles Allenbach1, Costa Georgantas1, Ruijia Wang1, Olivier Braissant3, Frederic Barbey4, John O Prior1, Diana Ballhausen2, David Viertl1. 1. Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne CH-1011 Lausanne, Switzerland. 2. Paediatric Metabolic Unit, Pediatrics, Woman-Mother-Child Department, University of Lausanne and University Hospital of Lausanne Switzerland. 3. Service of Clinical Chemistry, Lausanne University Hospital and University of Lausanne CH-1011 Lausanne, Switzerland. 4. Department of Immunology, Lausanne University Hospital and University of Lausanne CH-1011 Lausanne, Switzerland.
Abstract
INTRODUCTION: Evaluation of glomerular filtration rate is very important in both preclinical and clinical setting, especially in the context of chronic kidney disease. It is typically performed using 51Cr-EDTA or by imaging with 123I-Hippuran scintigraphy, which has a significantly lower resolution and sensitivity as compared to PET. 68Ga-EDTA represents a valid alternative due to its quick availability using a 68Ge/68Ga generator, while PET/CT enables both imaging of renal function and accurate quantitation of clearance of activity from both plasma and urine. Therefore, we aimed at investigating the use of 68Ga-EDTA as a preclinical tracer for determining renal function in a knock-in rat model known to present progressive decline of renal function. METHODS: 68Ga-EDTA was injected in 23 rats, either wild type (n=10) or knock-in (n=13). By applying a unidirectional, two-compartment model and Rutland-Patlak Plot linear regression analysis, split renal function was determined from the age of 6 weeks to 12 months. RESULTS: Glomerular filtration ranged from 0.025±0.01 ml/min at 6 weeks to 0.049±0.05 ml/min at 6 months in wild type rats. Glomerular filtration was significantly lower in knock-in rats at 6 and 12 months (P<0.01). No significant difference was observed in renal volumes between knock-in and wild type animals, based on imaging-derived volume calculations. CONCLUSIONS: 68Ga-EDTA turned out to be a very promising PET/CT tracer for the evaluation of split renal function. This method allowed detection of progressive renal impairment in a knock-in rat model. Additional validation in a human cohort is warranted to further assess clinical utility in both, healthy individuals and patients with renal impairment. AJNMMI
INTRODUCTION: Evaluation of glomerular filtration rate is very important in both preclinical and clinical setting, especially in the context of chronic kidney disease. It is typically performed using 51Cr-EDTA or by imaging with 123I-Hippuran scintigraphy, which has a significantly lower resolution and sensitivity as compared to PET. 68Ga-EDTA represents a valid alternative due to its quick availability using a 68Ge/68Ga generator, while PET/CT enables both imaging of renal function and accurate quantitation of clearance of activity from both plasma and urine. Therefore, we aimed at investigating the use of 68Ga-EDTA as a preclinical tracer for determining renal function in a knock-in rat model known to present progressive decline of renal function. METHODS: 68Ga-EDTA was injected in 23 rats, either wild type (n=10) or knock-in (n=13). By applying a unidirectional, two-compartment model and Rutland-Patlak Plot linear regression analysis, split renal function was determined from the age of 6 weeks to 12 months. RESULTS: Glomerular filtration ranged from 0.025±0.01 ml/min at 6 weeks to 0.049±0.05 ml/min at 6 months in wild type rats. Glomerular filtration was significantly lower in knock-in rats at 6 and 12 months (P<0.01). No significant difference was observed in renal volumes between knock-in and wild type animals, based on imaging-derived volume calculations. CONCLUSIONS: 68Ga-EDTA turned out to be a very promising PET/CT tracer for the evaluation of split renal function. This method allowed detection of progressive renal impairment in a knock-in rat model. Additional validation in a human cohort is warranted to further assess clinical utility in both, healthy individuals and patients with renal impairment. AJNMMI
Authors: I Barić; J Zschocke; E Christensen; M Duran; S I Goodman; J V Leonard; E Müller; D H Morton; A Superti-Furga; G F Hoffmann Journal: J Inherit Metab Dis Date: 1998-06 Impact factor: 4.982
Authors: Dawei Jiang; Zhilei Ge; Hyung-Jun Im; Christopher G England; Dalong Ni; Junjun Hou; Luhao Zhang; Christopher J Kutyreff; Yongjun Yan; Yan Liu; Steve Y Cho; Jonathan W Engle; Jiye Shi; Peng Huang; Chunhai Fan; Hao Yan; Weibo Cai Journal: Nat Biomed Eng Date: 2018-11-08 Impact factor: 25.671
Authors: Ying Ding; Du Zhang; Min Wang; Li Zhang; Yu Liu; Yinqian Deng; Dawei Jiang; Yuqing Liu; Wei Cao Journal: Am J Nucl Med Mol Imaging Date: 2022-04-15